Alliancebernstein L.P. Bio Techne Corp Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Bio Techne Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 169,632 shares of TECH stock, worth $12.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

169,632

Previous 172,170 1.47%

Holding current value

$12.1 Million

Previous $12.3 Million 9.89%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$70.96 - $82.35 $180,096 - $209,004	-2,538 Reduced 1.47%	169,632 $13.6 Million
Q2 2024 Aug 14, 2024	BUY	$62.12 - $84.15 $756,994 - $1.03 Million	12,186 Added 7.62%	172,170 $12.3 Million
Q1 2024 May 14, 2024	SELL	$65.98 - $77.09 $1.11 Million - $1.29 Million	-16,788 Reduced 9.5%	159,984 $11.3 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $141,848 - $210,020	2,685 Added 1.54%	176,772 $13.6 Million
Q3 2023 Nov 14, 2023	SELL	$67.52 - $89.42 $4.32 Million - $5.72 Million	-63,975 Reduced 26.87%	174,087 $11.9 Million
Q2 2023 Aug 15, 2023	BUY	$73.76 - $85.98 $2.31 Million - $2.69 Million	31,308 Added 15.14%	238,062 $19.4 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $1.07 Million - $1.29 Million	14,876 Added 7.75%	206,754 $15.3 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $11.6 Million - $50.6 Million	143,544 Added 296.98%	191,878 $15.9 Million
Q3 2022 Nov 15, 2022	SELL	$282.54 - $391.85 $73,177 - $101,489	-259 Reduced 0.53%	48,334 $13.7 Million
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $205,218 - $285,977	-636 Reduced 1.29%	48,593 $16.8 Million
Q1 2022 May 13, 2022	SELL	$353.85 - $487.79 $119,247 - $164,385	-337 Reduced 0.68%	49,229 $21.3 Million
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $1.38 Million - $1.59 Million	-3,030 Reduced 5.76%	49,566 $25.6 Million
Q3 2021 Nov 10, 2021	SELL	$444.87 - $538.88 $4.85 Million - $5.88 Million	-10,910 Reduced 17.18%	52,596 $25.5 Million
Q2 2021 Jul 30, 2021	SELL	$387.35 - $450.26 $1.46 Million - $1.7 Million	-3,768 Reduced 5.6%	63,506 $28.6 Million
Q1 2021 May 06, 2021	BUY	$314.62 - $411.0 $358,981 - $468,951	1,141 Added 1.73%	67,274 $25.7 Million
Q4 2020 Feb 08, 2021	SELL	$246.9 - $321.87 $236,777 - $308,673	-959 Reduced 1.43%	66,133 $21 Million
Q3 2020 Nov 12, 2020	SELL	$232.22 - $282.96 $23,686 - $28,861	-102 Reduced 0.15%	67,092 $16.6 Million
Q2 2020 Aug 13, 2020	BUY	$185.43 - $279.56 $585,217 - $882,291	3,156 Added 4.93%	67,194 $17.7 Million
Q1 2020 May 14, 2020	SELL	$161.17 - $221.51 $66,079 - $90,819	-410 Reduced 0.64%	64,038 $12.1 Million
Q4 2019 Feb 18, 2020	BUY	$189.68 - $222.09 $282,623 - $330,914	1,490 Added 2.37%	64,448 $14.1 Million
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $220,272 - $260,064	-1,200 Reduced 1.87%	62,958 $12.3 Million
Q2 2019 Aug 14, 2019	SELL	$188.72 - $215.43 $1.43 Million - $1.64 Million	-7,591 Reduced 10.58%	64,158 $13.4 Million
Q1 2019 May 14, 2019	BUY	$136.09 - $200.44 $1.1 Million - $1.62 Million	8,081 Added 12.69%	71,749 $14.2 Million
Q4 2018 Feb 13, 2019	BUY	$132.75 - $203.8 $2.92 Million - $4.49 Million	22,029 Added 52.9%	63,668 $9.21 Million
Q3 2018 Nov 08, 2018	BUY	$147.44 - $204.11 $2.85 Million - $3.94 Million	19,296 Added 86.36%	41,639 $8.5 Million
Q2 2018 Aug 13, 2018	BUY	$144.9 - $165.58 $80,999 - $92,559	559 Added 2.57%	22,343 $3.31 Million
Q1 2018 May 14, 2018	SELL	$131.46 - $151.04 $511,379 - $587,545	-3,890 Reduced 15.15%	21,784 $3.29 Million
Q4 2017 Feb 13, 2018	SELL	$121.17 - $134.75 $9,693 - $10,780	-80 Reduced 0.31%	25,674 $3.33 Million
Q3 2017 Nov 13, 2017	BUY	$113.59 - $123.78 $2.93 Million - $3.19 Million	25,754	25,754 $3.11 Million

Others Institutions Holding TECH

# of Institutions

601

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Bio Techne Corp Transaction History